Current collaborations
An invitation to build winning collaborations
Recognizing the value of scientific advances that are made outside of Novartis, we actively seek collaborators with the best technologies and early-stage compounds that complement our objectives. We have a culture designed to build fair, effective and mutually beneficial alliances.
The importance that we place on building winning collaborations is seen in the early and substantial involvement of our senior management. We devote the same level of commitment to licensed opportunities as to internally discovered product candidates. Our alliance and business development teams remain actively involved with each project throughout its duration to ensure effective communication and to foster an open, productive environment for collaboration.
For early discovery such as targets, software, assay tools, chemistry, biology, disease models, screening technology, imaging tools and pre-clinical (pre-Proof-of-concept) compounds, please
Collaborate with us
Research at NIBR
Our global research efforts begin and end with the patient.
Our approach
Our approach is to form a close connection between research and the clinic.